DMP 323

Known as: 2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,3-bis((4-(hydroxymethyl)phenyl)methyl)-4,7-bis(phenylmethyl)-, (4alpha,5alpha,6beta,7beta)-, DMP-323 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2003
012319942003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
W(CO)(6)-catalyzed carbonylation provides an alternative to phosgene or phosgene derivatives such as 1,1-carbonyldiimidazole (CDI… (More)
Is this relevant?
2000
2000
Protease inhibitors are widely used in the treatment of human immunodeficiency virus type 1 (HIV-1)-infected individuals and show… (More)
Is this relevant?
1996
1996
DMP 323, a potent HIV-1 protease inhibitor, has been synthesized by an efficient stereoselective process, amenable to large scale… (More)
Is this relevant?
1994
1994
DMP 323 is a potent inhibitor of the protease of human immunodeficiency virus (HIV), with antiviral activity against both HIV… (More)
Is this relevant?
1994
1994
DMP 323 is a symmetrically substituted cyclic urea compound with demonstrated activity against human immunodeficiency virus (HIV… (More)
Is this relevant?
1994
1994
DMP 323, a C-2-symmetrical cyclic urea, is representative of a new class of inhibitors of human immunodeficiency virus protease… (More)
Is this relevant?